Kraken Offers US Securities Through Strategic Partnership with Alpaca
Kraken, one of the world’s most trusted and longest-standing cryptocurrency platforms with more than 15 million global clients, now offers US securities to US-residing clients. By expanding their product offering, Kraken continues to bridge the gap between digital and traditional assets– furthering their position as an institutional grade, multi-asset-class trading platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428924377/en/
Kraken has launched this new asset class through a strategic partnership with Alpaca– an API-first brokerage platform and self-clearing broker-dealer for stocks, ETFs, and options who serves hundreds of financial services and millions of brokerage accounts around the world.
Through this partnership, Kraken is offering its users access to a large and diverse investable asset universe, combining their best-in-class crypto platform of more than 300 digital assets and 6 different fiat currencies with over 11,000 stocks and ETFs. Kraken’s recent acquisition of NinjaTrader, a futures trading platform, shows their commitment in providing more investment opportunities to their clients.
“We are excited to work with Alpaca to bring US equities to our clients,” said Nick LaMaina, Managing Director of Kraken. “This collaboration accelerates Kraken’s vision of combining traditional and digital asset classes into one platform, enhancing the user experience of both new and sophisticated traders while maintaining the highest standards of trust and security.”
Alpaca’s Broker API empowers global partners, like Kraken, with notional and fractional orders, low-latency trade execution, and its self-clearing platform to deliver equities trading commission-free.
“We’re excited to congratulate Kraken on their incredible milestone to offer US securities. Their forward-thinking approach to combine multiple asset types into one consolidated platform shows how dedicated they remain to serving the needs of their global customer base, and we’re thrilled to be a part of their journey,” said Yoshi Yokokawa, CEO & Co-Founder of Alpaca.
As Kraken looks ahead, they will continue to explore adding more traditional asset classes, like options, and how they can offer this around the world.
About Alpaca
Alpaca is a US-headquartered self-clearing broker-dealer and brokerage infrastructure for stocks, ETFs, options, and crypto– raising over USD170 million in funding. Alpaca is backed by top-tier investors globally, including Portage Ventures, Spark Capital, Tribe Capital, Social Leverage, Horizons Ventures, Unbound, SBI Group, Derayah Financial, Elefund, and Y Combinator. For more information, please visit: alpaca.markets
About Kraken
Kraken is one of the world’s largest digital asset exchanges and the leader in euro volume and liquidity. Globally, Kraken’s client base trades more than 300 digital assets and 6 different fiat currencies, including GBP, EUR, USD, CAD, CHF, and AUD. Kraken was founded in 2011 and was one of the first exchanges to offer spot trading with margin, regulated derivatives and index services. Kraken is trusted by well over 15 million traders and institutions around the world and offers professional, round the clock online support. For more information, please visit www.kraken.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250428924377/en/
Contacts
Media Contact:
press@alpaca.markets
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Forrester Announces The EMEA Recipients Of Its 2025 Customer-Obsessed Enterprise Award21.5.2025 12:00:00 EEST | Press release
Forrester (Nasdaq: FORR) today announced that Brenntag and e& are the winners of its 2025 Customer-Obsessed Enterprise Award for Europe, Middle East, and Africa (EMEA). The award recognises organisations that place their customers at the centre of their leadership, strategy, and operations to drive business outcomes, including building sustainable growth, customer loyalty, and employee engagement. Both recipients will be celebrated at CX Summit EMEA, a leading event for CX, B2C marketing, and digital leaders to learn best practices and receive actionable advice, being held in London and digitally from 2–4 June 2025. This year’s recognition highlights two firms: one leading the charge on customer obsession in the B2B sector and the other in B2C. Brenntag, a global leader in chemicals and ingredients distribution, has been selected for embedding customer obsession into its B2B operations spanning 72 countries. The firm earned the award for operationalising customer obsession through key
Legora Attracts $80 Million Series B Funding as Top Global Law Firms and Legal Teams Rush to Adopt Its Collaborative AI21.5.2025 11:00:00 EEST | Press release
Today, Legora announces an $80 million funding round led by ICONIQ and General Catalyst, with continued support from existing investors Redpoint Ventures, Benchmark, and Y Combinator. This latest round is a strong endorsement of Legora’s product quality, velocity and the remarkable traction it has achieved globally—underscored by its rapid progression from inception to Series B in under two years. The deal comes as adoption of legal AI surges across the world. Legora is at the forefront of this shift - with lawyers across 250 firms and legal teams in 20 markets globally making daily use of its platform to review and research with precision, draft smarter, and collaborate seamlessly. Legora operates out of New York, London, and Stockholm, with 100 employees drawn from some of the world’s leading global law firms and tech companies. Max Junestrand, CEO and founder of Legora said: “The investment is a clear validation of the value our product is delivering to lawyers around the world. Whi
SEKISUI CHEMICAL: Victory in German Patent Infringement Lawsuit Concerning PVB Interlayer Films21.5.2025 11:00:00 EEST | Press release
The High Performance Plastics Company (President : Akira Asano) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter “SEKISUI CHEMICAL”) hereby notifies that it has obtained judgments in its favor (hereinafter referred to as “the Judgments”) from the District Court Munich I on April 17, 2025, in the patent infringement litigation (docket No. 7 O 12401/24 and 7 O 12476/24) against Kuraray Europe GmbH (hereinafter referred to as “Kuraray Europe”), a subsidiary of Kuraray Co., Ltd which we previously announced in the press release dated October 16, 2024, titled “Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany.” This judgments found that the sound-insulating wedge products manufactured and sold by Kuraray Europe, namely “‘Trosifol’ The Wedge Acoustic” and “‘Trosifol’ The Wedge Acoustic Shadeband” (hereinafter collectively referred to as “Kuraray Products”) infringe European Patent No.
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom